The Precision Peptide Co (FRA:XU0) LT-Debt-to-Total-Asset: 0.00 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XU0 The Precision Peptide Co Inc FRA:XU0
40 GF Score
Price €0.28
! 5 Warning Signs
View Full Analysis

What is The Precision Peptide Co LT-Debt-to-Total-Asset?

The Precision Peptide Co FRA:XU0 40 LT-Debt-to-Total-Asset is 0.00 as of Apr. 2026. GuruFocus rates FRA:XU0 with a GF Score™ of 40/100. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. The Precision Peptide Co's long-term debt to total assests ratio for the quarter that ended in Apr. 2026 was 0.00.

The Precision Peptide Co's long-term debt to total assets ratio stayed the same from Apr. 2025 (0.00) to Apr. 2026 (0.00).

The Precision Peptide Co  (FRA:XU0) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

The Precision Peptide Co LT-Debt-to-Total-Asset Related Terms

The Precision Peptide Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co LT-Debt-to-Total-Asset Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
LT-Debt-to-Total-Asset
0.00 0.00 0.00 0.00 0.00

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:XU0
40GF Score
The Precision Peptide Co Inc FRA:XU0
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co LT-Debt-to-Total-Asset Calculation

The Precision Peptide Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2025 is calculated as

LT Debt to Total Assets (A: Oct. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Oct. 2025 )/Total Assets (A: Oct. 2025 )
=0/0.817
=0.00

The Precision Peptide Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Apr. 2026 is calculated as

LT Debt to Total Assets (Q: Apr. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Apr. 2026 )/Total Assets (Q: Apr. 2026 )
=0/0.929
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
The Precision Peptide Co (FRA:XU0) has a LT-Debt-to-Total-Asset of 0.00 as of Apr. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's LT-Debt-to-Total-Asset too high?
The Precision Peptide Co's current LT-Debt-to-Total-Asset is 0.00. Overall, The Precision Peptide Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's LT-Debt-to-Total-Asset compare to KHC and GIS?
The Precision Peptide Co's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (FRA:XU0) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. The Precision Peptide Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For The Precision Peptide Co (FRA:XU0), the current LT-Debt-to-Total-Asset is 0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges PNGAF:USABPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
40GF Score

Get the complete analysis for FRA:XU0

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.28
Price